Oppenheimer Recommends Buying Questcor (QCOR) On Weakness
Tweet
Share
E-mail
Get Alerts QCOR Hot Sheet
Price: $93.60 --0%
Rating Summary:
5 Buy, 7 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
5 Buy, 7 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Analysts at Oppenheimer came out to defend Questcor Pharmaceuticals (NASDAQ: QCOR) Thursday following yesterday's 15 percent drubbing ahead of a forthcoming negative report from TheStreetSweeper.org.
The firm "we believe these allegations are unfounded and would be buyers of the stock." There is no evidence to date that QCOR promotes Acthar for off-label indications, only for the 19 on-label indication, they also said.
"We would be buyers of QCOR on this weakness but expect this issue to present an overhang until further clarity is provided next week."
The firm maintained an Outperform rating and $53 price target on QCOR.
For an analyst ratings summary and ratings history on Questcor Pharmaceuticals click here. For more ratings news on Questcor Pharmaceuticals click here.
Shares of Questcor Pharmaceuticals closed at $35.34 yesterday.
The firm "we believe these allegations are unfounded and would be buyers of the stock." There is no evidence to date that QCOR promotes Acthar for off-label indications, only for the 19 on-label indication, they also said.
"We would be buyers of QCOR on this weakness but expect this issue to present an overhang until further clarity is provided next week."
The firm maintained an Outperform rating and $53 price target on QCOR.
For an analyst ratings summary and ratings history on Questcor Pharmaceuticals click here. For more ratings news on Questcor Pharmaceuticals click here.
Shares of Questcor Pharmaceuticals closed at $35.34 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Fiserv (FISV) PT Lowered to $60 at Freedom Broker
- Intuitive Machines Inc. (LUNR) PT Lowered to $32 at Cantor Fitzgerald, Reaffirms Overweight Rating
- Kenon Holdings (KEN) halted, news pending
Create E-mail Alert Related Categories
Analyst Comments, Trader TalkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
